Italy· 026689051

CROMATONFERRO

A ferrous gluconate product containing ferroso gluconato, registered in Italy by A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L., on the national reimbursement list. The same ATC class is registered in 5 of our 19 countries.

Reimbursed in Italy (AIFA class A)ATC B03AA03

Checked against AIFA (Italy) on

Informational only — not a medical device.

SOURCE REGISTER · ITAIFA (Italy)normalisedCROMATONFERROATCB03AA03REGISTER NO.026689051PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Ferrous gluconate is registered in 5 of 19 countries.

Countries holding a registration under ATC B03AA03 (ferrous gluconate), each read from that country’s own register.

  • This record: Italy, from AIFA (Italy)
  • 4 of them publish a price we can compare per daily dose

Ferrous gluconate · ATC B03AA03

5 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous gluconate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • Italy: $0.54 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Ferrous gluconate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • IT Italy$0.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AIFA (Italy)
Active substance
Ferroso gluconato
Manufacturer
A.MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L.
Country
Italy (IT)
ATC code
B03AA03
ATC class
Ferrous gluconate
Defined daily dose
0.2 g, O
Reimbursed
Yes
Source register
AIFA (Italy)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • aic
    026689051
    "80 MG COMPRESSE EFFERVESCENTI" 30 COMPRESSE EFFERVESCENTI
    EUR 5.74

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

79 interactions on record for ferrous gluconate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ferrous gluconate · interactions on record

79 records

  • 3 severe
  • 69 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/05d4676f-b26e-4666-b125-93fdbc1062f4
GET /v1/drugs/05d4676f-b26e-4666-b125-93fdbc1062f4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pack": "\"80 MG COMPRESSE EFFERVESCENTI\" 30 COMPRESSE EFFERVESCENTI",
  "source": "aifa",
  "currency": "EUR",
  "substance": "Ferroso gluconato",
  "reference_pack": "30 UNITA' 80 MG - USO ORALE",
  "public_price_eur": 5.74,
  "ssn_reference_price_eur": 8.76
}

See everything about ferrous gluconate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.